The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Employees - 769,
CEO - Ms. Marla Malcolm Beck,
Sector - Consumer Defensive,
Country - US,
Market Cap - 166.57M
Altman ZScore(max is 10): 0.23, Piotroski Score(max is 10): 7, Working Capital: $408948000, Total Assets: $685683000, Retained Earnings: $-508000000, EBIT: -17083000, Total Liabilities: $633880000, Revenue: $334299000
- Current Price $1.33 - Analyst Target Price $1.57| Ticker | SKIN |
| Index | RUT |
| Curent Price | 1.33 |
| Change | -10.14% |
| Market Cap | 166.57M |
| Average Volume | 608.07K |
| Income | -29.10M |
| Sales | 334.29M |
| Book Value/Share | 0.41 |
| Cash/Share | 2.95 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 769 |
| Moving Avg 20days | -0.69% |
| Moving Avg 50days | -9.89% |
| Moving Avg 200days | -16.19% |
| Shares Outstanding | 124.92M |
| Earnings Date | Mar 12 AMC |
| Inst. Ownership | 59.18% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 0.50 |
| Price/Book | 3.21 |
| Price/Cash | 0.45 |
| Price/FCF | 10.83 |
| Quick Ratio | 5.99 |
| Current Ratio | 7.00 |
| Debt/Equity | 10.97 |
| Return on Assets | -3.60% |
| Return on Equity | -52.34% |
| Return on Investment | -4.73% |
| Gross Margin | 54.53% |
| Ops Margin | -20.27% |
| Profit Margin | -8.70% |
| RSI | 47.21 |
| BETA(β) | 0.85 |
| From 52week Low | 46.15% |
| From 52week High | -67.48% |
| EPS | -0.43 |
| EPS next Year | -0.21 |
| EPS next Qtr | -0.13 |
| EPS this Year | -22.40% |
| EPS next 5 Year | -5.45% |
| EPS past 5 Year | -48.09% |
| Sales past 5 Year | 24.66% |
| EPS Y/Y | 69.61% |
| Sales Y/Y | -16.00% |
| EPS Q/Q | -13.70% |
| Sales Q/Q | -13.74% |
| Sales Surprise | 8.18% |
| EPS Surprise | 29.70% |
| ATR(14) | 0.13 |
| Perf Week | -2.21% |
| Perf Month | 3.10% |
| Perf Quarter | -16.35% |
| Perf Year | -67.08% |
| Perf YTD | -16.35% |
| Target Price | 1.57 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer